시장보고서
상품코드
1756483

세계의 면역조직화학(IHC) 시장 : 제공 제품별, 용도별, 최종 사용자별, 국가별, 지역별 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Immunohistochemistry Market, By Offering, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 387 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

면역조직화학 시장 규모는 2024년 28억 7,600만 달러로 2024-2032년에 걸쳐 CAGR 6.6%로 성장할 전망입니다.

면역조직화학 시장 - 시장 역학

만성 질환의 유병률 증가

만성 질환, 특히 암의 발병률 증가는 면역조직화학 시장의 주요 동력입니다. IHC는 조직 샘플에서 특정 바이오마커를 검출하여 암을 정확하게 진단하고 분류하는 데 중요한 역할을 합니다. 이를 통해 개인 맞춤형 치료 계획과 더 나은 환자 치료 결과를 얻을 수 있습니다. 인구 고령화 및 생활 습관 요인으로 인해 전 세계 암 발병률 및 기타 만성 질환이 증가함에 따라 IHC와 같은 정밀한 진단 기술에 대한 수요가 증가하고 있습니다. 또한, 연구 및 의약품 개발에 IHC의 사용이 확대됨에 따라 표적 치료 및 정밀 의학의 발전이 지원되어 시장 성장이 더욱 가속화될 것입니다.

면역조직화학 시장 - 주요 인사이트

당사의 리서치 애널리스트에 따르면 세계의 면역조직화학 시장은 2024-2032년 사이에 약 6.6%의 연평균 성장률(CAGR)로 성장할 전망입니다.

2023년 시장 세분화에서는 항체 부문이 시장을 독점하고 있습니다.

용도별로 진단 용도 부문이 2023년에 가장 수익을 올렸습니다.

지역별로는 2023년 북미가 가장 수익이 높은 지역이었습니다.

면역조직화학 시장 - 세분화 분석

세계의 면역조직화학 시장은 제공 제품, 용도, 최종 사용자, 지역의 4가지 범주로 분류됩니다.

면역조직화학(IHC) 시장은 제품에 따라 항체, 시약, 장비, 키트 및 소프트웨어로 분류됩니다. 항체는 조직 샘플에서 표적 항원에 특이적으로 결합하는 데 필수적이며, IHC 공정에서 중요한 컴포넌트입니다. 시약은 염색 및 시각화의 다양한 단계를 지원하며, 장비에는 테스트를 수행하고 분석하는 데 사용되는 현미경, 슬라이드 스캐너 및 자동 염색 시스템이 포함됩니다. 키트는 즉시 사용할 수 있는 항체와 시약의 조합을 제공하여 실험실의 워크플로우를 간소화합니다. 소프트웨어 솔루션은 이미지 분석 및 데이터 관리를 지원하여 정확성과 효율성을 향상시킵니다. 이러한 부문 중 항체는 바이오마커 식별에 대한 근본적인 역할, 다양하고 고도로 특이적인 항체에 대한 높은 수요, 그리고 전 세계 진단 및 연구 용도 분야에서 상당한 수익과 채택을 촉진하는 지속적인 혁신으로 인해 시장을 지배하고 있습니다.

면역조직화학(IHC) 시장은 용도별로 진단 용도, 연구 용도, 법의학 용도로 분류됩니다. 진단 용도는 환자 조직 샘플에서 특정 바이오마커를 검출하여 질병을 식별하고 분류하는 데 IHC 기술을 사용하는 것을 의미합니다. 연구 용도는 실험실 및 학술 기관에서 질병 메커니즘 연구, 약물 개발, 바이오마커 발견에 IHC를 활용하는 것을 포함합니다. 법의학 용도 분야는 범죄 수사에서 조직 유형 및 세포 구성 요소를 식별하기 위해 IHC를 사용합니다. 이 중 진단 용도 분야는 특히 종양학 분야에서 정확하고 조기 질병 검출에 대한 요구가 증가함에 따라 시장에서 가장 큰 점유율을 차지하고 있습니다. 만성 질환의 유병률 증가와 개인 맞춤형 의학의 채택이 증가함에 따라 임상 진단 분야에서 IHC에 대한 수요가 크게 증가하여 전 세계적으로 가장 큰 용도 부문이 되었습니다.

면역조직화학 시장 - 지역적 인사이트

지역적으로 면역조직화학 시장은 북미, 아시아태평양, 라틴 아메리카, 유럽, 중동 및 아프리카에 분포되어 있습니다. 이러한 지역은 사업을 유치하는 국가에 따라 더 세분화됩니다.

북미는 첨단 의료 인프라, 혁신적인 진단 기술의 높은 채택률, 상당한 연구 투자에 힘입어 면역조직화학 시장에서 지배적인 지역입니다. 주요 제약 및 생명공학 기업의 존재와 암 및 만성 질환 연구에 대한 정부의 강력한 재정 지원이 시장 성장을 촉진하고 있습니다. 또한, 개인 맞춤형 의학 및 조기 질병 진단에 대한 인식이 높아짐에 따라 IHC 기술의 광범위한 사용이 지원되고 있습니다. 미국은 정밀한 진단 도구에 대한 강력한 수요, 잘 확립된 보험 적용 정책, 그리고 대규모 환자 풀을 바탕으로 이 지역을 선도하고 있으며, 북미는 전 세계 면역조직화학 시장에서 주요 수익 원으로 자리매김하고 있습니다.

유럽은 잘 발달된 의료 시스템과 암 및 기타 만성 질환의 유병률 증가로 인해 면역조직화학 시장에서 상당한 점유율을 차지하고 있습니다. 독일, 영국, 프랑스와 같은 국가들은 정부 정책과 연구 자금의 지원에 힘입어 첨단 IHC 기술을 가장 먼저 채택한 국가들입니다. 정밀 의학에 대한 관심의 증가와 바이오 제약 연구 활동의 확대는 수요를 더욱 촉진하고 있습니다. 유럽은 또한 강력한 진단 실험실 및 학술 기관 네트워크의 혜택을 받아 임상 진단 및 연구 목적 모두에 IHC 사용을 촉진하여 전 세계적으로 지배적인 지역 시장으로 자리매김하고 있습니다.

면역조직화학 시장 - 경쟁 구도

면역조직화학 시장은 Thermo Fisher Scientific, Danaher Corporation, F. Hoffmann-La Roche Ltd 및 Bio-Rad Laboratories와 같은 기존 업체들이 지배하고 있습니다. 이 기업들은 혁신, 품질 및 규정 준수에 중점을 두고 임상 진단 및 연구를 위한 다양한 항체, 시약, 키트 및 기기를 공급하고 있습니다. 이들은 제품 민감도와 특이성을 높이기 위해 R&D에 상당한 투자를 하고 있으며, 개인 맞춤형 의학 및 정확한 질병 진단에 대한 증가하는 수요에 부응하고 있습니다. 신흥 기업들도 새로운 기술을 개발하여 IHC 방법론의 지속적인 개선을 촉진하고 전 세계 의료 및 연구 분야에서 IHC의 채택을 확대하는 경쟁을 촉진함으로써 기여하고 있습니다.

목차

제1장 면역조직화학 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 분석
  • 경쟁 인사이트

제3장 면역조직화학의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장의 미래 동향

제4장 면역조직화학산업연구

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 매핑
  • 규제 틀 분석

제5장 면역조직화학 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 면역조직화학 시장 상황

  • 면역조직화학 시장 점유율 분석(2023년)
  • 주요 제조업체별 분석 데이터
    • 베테랑 선수의 분석
    • 신흥기업의 분석

제7장 면역조직화학 시장 - 제공 제품별

  • 개요
    • 제공 제품별 부문 점유율 분석
    • 항체
      • 1차 항체
      • 2차 항체
      • 단일 클론 항체
      • 다클론 항체
    • 시약
      • 조직학적 염색
      • 차단 혈청 및 시약
      • 발색 기질
      • 고정 시약
      • 희석제
      • 유기용매
      • 단백질 분해 효소
      • 기타 시약
    • 기기
      • 슬라이드 염색 시스템
      • 조직 처리 시스템
      • 슬라이드 스캐너
      • 기타 기기
    • 키트
      • 인간 면역조직화학 키트
      • 동물 면역조직화학 키트
    • 소프트웨어

제8장 면역조직화학 시장 : 용도별

  • 개요
    • 용도별 부문 점유율 분석
    • 진단 용도
      • 감염증
      • 신장 질환
      • 자가면역질환
      • 신경질환
      • 기타
    • 연구 용도
      • 의약품 개발 및 검사
      • 기타 연구 용도
    • 법의학 용도

제9장 면역조직화학 시장 - 최종 사용자별

  • 개요
    • 최종 사용자별 부문 점유율 분석
    • 병원과 진단 실험실
    • 학술연구기관과 계약연구기관
    • 기타

제10장 면역조직화학시장 : 지역

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 영국
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 한국
    • 일본
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 튀르키예
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 : 면역조직화학 산업

  • 경쟁 대시보드
  • 기업 프로파일
    • F. Hoffmann-La Roche Ltd
    • Danaher Corporation
    • Agilent Technologies, Inc
    • Thermo Fisher Scientific Inc.
    • Merck Kgaa
    • Bio-Rad Laboratories, Inc
    • Bio-Techne
    • Becton, Dickinson And Company
    • Takara Bio Inc.
    • Enzo Biochem Inc.
    • Sino Biological, Inc.
    • Sakura Finetek Japan Co., Ltd.
    • Cell Signaling Technology, Inc.
    • Bio Sb
    • Origene Technologies, Inc
    • Eaglebio
    • Biocare Medical, Llc
    • Elabscience Bionovation Inc.
    • Biogenex
    • Diagnostic Biosystems Inc.
    • Histo-Line Laboratories
    • Rockland Immunochemicals, Inc.
    • Candor Bioscience Gmbh
    • Genemed BIoTechnologies, Inc.
    • 기타

제12장 애널리스트의 전방위 전망

HBR 25.07.02

REPORT HIGHLIGHT

Immunohistochemistry Market size was valued at USD 2,876 Million in 2024, expanding at a CAGR of 6.6% from 2024 to 2032.

The Immunohistochemistry (IHC) market refers to the industry focused on the production and sale of reagents, antibodies, detection kits, instruments, and related services used for IHC techniques. Immunohistochemistry is a laboratory method that uses antibodies to detect specific antigens in tissue samples, aiding in disease diagnosis, especially cancer, and research. The market encompasses products used in hospitals, diagnostic labs, research institutes, and pharmaceutical companies. Growth in this market is driven by rising prevalence of chronic diseases, technological advancements, and increasing demand for personalized medicine and accurate diagnostic tools globally.

Immunohistochemistry Market- Market Dynamics

Increasing Prevalence of Chronic Diseases

The rising incidence of chronic diseases, especially cancer, is a major driver of the immunohistochemistry market. IHC plays a crucial role in accurately diagnosing and classifying cancers by detecting specific biomarkers in tissue samples. This enables personalized treatment plans and better patient outcomes. As global cancer rates and other chronic illnesses grow due to aging populations and lifestyle factors, the demand for precise diagnostic techniques like IHC increases. Additionally, the expanding use of IHC in research and drug development further propels market growth by supporting advancements in targeted therapies and precision medicine.

Immunohistochemistry Market- Key Insights

According to our research analyst, the global Immunohistochemistry Market is expected to develop at a CAGR of approximately 6.6% between 2024-2032.

Segmented by Offerings in 2023, the Antibodies category dominated the market.

Based on Application, the Diagnostic Applications segment generated the most income in 2023.

On the basis of region, in 2023, North America was the region with the highest revenue.

Immunohistochemistry Market- Segmentation Analysis:

The global Immunohistochemistry Market is divided into Four categories: Offering, Application, End User, and Region.

The Immunohistochemistry (IHC) market is segmented by offering into Antibodies, Reagents, Equipment, Kits, and Software. Antibodies are essential for specifically binding to target antigens in tissue samples, making them a critical component in IHC processes. Reagents support various stages of staining and visualization, while Equipment includes microscopes, slide scanners, and automated staining systems used to perform and analyze tests. Kits provide ready-to-use combinations of antibodies and reagents, simplifying workflows for laboratories. Software solutions aid in image analysis and data management, enhancing accuracy and efficiency. Among these segments, Antibodies dominate the market due to their fundamental role in identifying biomarkers, high demand for diverse and highly specific antibodies, and continuous innovations, which drive significant revenue and adoption across diagnostic and research applications worldwide.

The Immunohistochemistry (IHC) market is categorized by application into Diagnostic Applications, Research Applications, and Forensic Applications. Diagnostic applications represent the use of IHC techniques to identify and classify diseases, particularly cancers, by detecting specific biomarkers in patient tissue samples. Research applications involve studying disease mechanisms, drug development, and biomarker discovery using IHC in laboratories and academic settings. Forensic applications use IHC for identifying tissue types and cellular components in criminal investigations. Among these, Diagnostic Applications hold the largest share of the market due to the growing need for precise and early disease detection, especially in oncology. The rising prevalence of chronic diseases and increasing adoption of personalized medicine strongly drive the demand for IHC in clinical diagnostics, making it the dominant application segment globally.

Immunohistochemistry Market- Geographical Insights

Geographically, the Immunohistochemistry Market is distributed throughout North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa. These regions are further divided based on the nations bringing in business.

North America is a dominant region in the Immunohistochemistry market, driven by advanced healthcare infrastructure, high adoption of innovative diagnostic technologies, and significant research investments. The presence of major pharmaceutical and biotechnology companies, coupled with strong government funding for cancer and chronic disease research, fuels market growth. Additionally, increasing awareness about personalized medicine and early disease diagnosis supports widespread use of IHC techniques. The U.S. leads the region with robust demand for precise diagnostic tools, well-established reimbursement policies, and a large patient pool, making North America a key revenue contributor in the global immunohistochemistry market.

Europe holds a significant share in the Immunohistochemistry market due to its well-developed healthcare systems and increasing prevalence of cancer and other chronic diseases. Countries like Germany, the UK, and France are at the forefront of adopting advanced IHC technologies, supported by government initiatives and research funding. The rising focus on precision medicine and expanding biopharmaceutical research activities further drive demand. Europe also benefits from a strong network of diagnostic laboratories and academic institutions, promoting the use of IHC for both clinical diagnostics and research purposes, positioning it as a dominant regional market globally.

Immunohistochemistry Market- Competitive Landscape:

The Immunohistochemistry market is dominated by established players like Thermo Fisher Scientific, Danaher Corporation, F. Hoffmann-La Roche Ltd, and Bio-Rad Laboratories. These companies focus heavily on innovation, quality, and regulatory compliance, offering a broad portfolio of antibodies, reagents, kits, and instruments for clinical diagnostics and research. They invest substantially in R&D to enhance product sensitivity and specificity, catering to the growing demand for personalized medicine and accurate disease detection. Emerging companies also contribute by developing novel technologies, driving competition that fosters continuous improvement in IHC methodologies and expands adoption in healthcare and research sectors worldwide.

Recent Developments:

In March 2025, Thermo Fisher Scientific Inc. launched a new automated IHC staining platform designed to improve throughput and reproducibility in clinical laboratories.

In December 2024, Danaher Corporation acquired a leading digital pathology software firm to enhance its IHC image analysis capabilities and integrate AI-driven diagnostics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IMMUNOHISTOCHEMISTRY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • F. Hoffmann-La Roche Ltd
  • Danaher Corporation
  • Agilent Technologies, Inc
  • Thermo Fisher Scientific Inc.
  • Merck Kgaa
  • Bio-Rad Laboratories, Inc
  • Bio-Techne
  • Becton, Dickinson And Company
  • Takara Bio Inc.
  • Enzo Biochem Inc.
  • Sino Biological, Inc.
  • Sakura Finetek Japan Co., Ltd.
  • Cell Signaling Technology, Inc.
  • Bio Sb
  • Origene Technologies, Inc
  • Eaglebio
  • Biocare Medical, Llc
  • Elabscience Bionovation Inc.
  • Biogenex
  • Diagnostic Biosystems Inc.
  • Histo-Line Laboratories
  • Rockland Immunochemicals, Inc.
  • Candor Bioscience Gmbh
  • Genemed Biotechnologies, Inc.
  • Others

GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING - MARKET ANALYSIS, 2019 - 2032

  • Antibodies
  • Primary Antibodies
  • Secondary Antibodies
  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Reagents
  • Histological Stains
  • Blocking Sera And Reagents
  • Chromogenic Substrates
  • Fixation Reagents
  • Diluents
  • Organic Solvents
  • Proteolytic Enzymes
  • Other Reagents
  • Equipment
  • Slide-Staining Systems
  • Tissue Processing Systems
  • Slide Scanners
  • Other Equipment
  • Kits
  • Human Immunohistochemistry Kits
  • Animal Immunohistochemistry Kits
  • Software

GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032

  • Diagnostic Applications
  • Cancer
  • Infectious Diseases
  • Nephrological Diseases
  • Autoimmune Diseases
  • Neurological Diseases
  • Other Diseases
  • Research Applications
  • Drug Development And Testing
  • Other Research Applications
  • Forensic Applications

GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032

  • Hospitals And Diagnostic Laboratories
  • Academic & Research Institutes And Contract Research Organizations
  • Other End Users

GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Immunohistochemistry Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Immunohistochemistry Market Snippet by Offerings
    • 2.1.2. Immunohistochemistry Market Snippet by Application
    • 2.1.3. Immunohistochemistry Market Snippet by End User
    • 2.1.4. Immunohistochemistry Market Snippet by Country
    • 2.1.5. Immunohistochemistry Market Snippet by Region
  • 2.2. Competitive Insights

3. Immunohistochemistry Key Market Trends

  • 3.1. Immunohistochemistry Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Immunohistochemistry Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Immunohistochemistry Market Opportunities
  • 3.4. Immunohistochemistry Market Future Trends

4. Immunohistochemistry Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Immunohistochemistry Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Immunohistochemistry Market Landscape

  • 6.1. Immunohistochemistry Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Immunohistochemistry Market - By Offerings

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Offerings, 2023 & 2032 (%)
    • 7.1.2. Antibodies
      • 7.1.2.1. Primary Antibodies
      • 7.1.2.2. Secondary Antibodies
      • 7.1.2.3. Monoclonal Antibodies
      • 7.1.2.4. Polyclonal Antibodies
    • 7.1.3. Reagents
      • 7.1.3.1. Histological Stains
      • 7.1.3.2. Blocking Sera And Reagents
      • 7.1.3.3. Chromogenic Substrates
      • 7.1.3.4. Fixation Reagents
      • 7.1.3.5. Diluents
      • 7.1.3.6. Organic Solvents
      • 7.1.3.7. Proteolytic Enzymes
      • 7.1.3.8. Other Reagents
    • 7.1.4. Equipment
      • 7.1.4.1. Slide-Staining Systems
      • 7.1.4.2. Tissue Processing Systems
      • 7.1.4.3. Slide Scanners
      • 7.1.4.4. Other Equipment
    • 7.1.5. Kits
      • 7.1.5.1. Human Immunohistochemistry Kits
      • 7.1.5.2. Animal Immunohistochemistry Kits
    • 7.1.6. Software

8. Immunohistochemistry Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Diagnostic Applications
      • 8.1.2.1. Cancer
      • 8.1.2.2. Infectious Diseases
      • 8.1.2.3. Nephrological Diseases
      • 8.1.2.4. Autoimmune Diseases
      • 8.1.2.5. Neurological Diseases
      • 8.1.2.6. Other Diseases
    • 8.1.3. Research Applications
      • 8.1.3.1. Drug Development and Testing
      • 8.1.3.2. Other Research Applications
    • 8.1.4. Forensic Applications

9. Immunohistochemistry Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Hospitals And Diagnostic Laboratories
    • 9.1.3. Academic & Research Institutes and Contract Research Organizations
    • 9.1.4. Other End Users

10. Immunohistochemistry Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Immunohistochemistry Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Immunohistochemistry Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. France
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. France Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.8.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. Italy Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.9.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. Spain
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. United Kingdom Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.10.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. United Kingdom
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. United Kingdom Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.11.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Russia
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Russia Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Netherlands
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Netherlands Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Sweden
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Sweden Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.2. Poland Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Immunohistochemistry Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. South Korea
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. South Korea Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.9.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. Japan Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.10.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Immunohistochemistry Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Immunohistochemistry Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Immunohistochemistry Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. F. Hoffmann-La Roche Ltd
    • 11.2.2. Danaher Corporation
    • 11.2.3. Agilent Technologies, Inc
    • 11.2.4. Thermo Fisher Scientific Inc.
    • 11.2.5. Merck Kgaa
    • 11.2.6. Bio-Rad Laboratories, Inc
    • 11.2.7. Bio-Techne
    • 11.2.8. Becton, Dickinson And Company
    • 11.2.9. Takara Bio Inc.
    • 11.2.10. Enzo Biochem Inc.
    • 11.2.11. Sino Biological, Inc.
    • 11.2.12. Sakura Finetek Japan Co., Ltd.
    • 11.2.13. Cell Signaling Technology, Inc.
    • 11.2.14. Bio Sb
    • 11.2.15. Origene Technologies, Inc
    • 11.2.16. Eaglebio
    • 11.2.17. Biocare Medical, Llc
    • 11.2.18. Elabscience Bionovation Inc.
    • 11.2.19. Biogenex
    • 11.2.20. Diagnostic Biosystems Inc.
    • 11.2.21. Histo-Line Laboratories
    • 11.2.22. Rockland Immunochemicals, Inc.
    • 11.2.23. Candor Bioscience Gmbh
    • 11.2.24. Genemed Biotechnologies, Inc.
    • 11.2.25. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제